SpyGlass Pharma Ownership | Who Owns SpyGlass Pharma?


OverviewFinancialsChart

SpyGlass Pharma Ownership Summary


SpyGlass Pharma is owned by 127.23% institutional investors, 42.83% insiders. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.95% of its assets in SpyGlass Pharma shares.

SGP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSpyGlass Pharma127.23%42.83%-70.06%
SectorHealthcare Stocks 35.52%11.86%52.62%
IndustryBiotech Stocks 35.67%11.81%52.52%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202635-25,353,391-127-35---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv317.05K0.95%-
JPMorgan Small Cap Growth A299.42K0.90%-
T. Rowe Price New Horizons229.81K0.69%-
US Small-Cap Growth II Equity Comp229.81K0.69%229.81K
Franklin Biotechnology Discv A(acc)USD190.67K0.57%-
Vanguard Institutional Extnd Mkt Idx Tr108.37K0.32%-
T. Rowe Price New Horizons Tr-A104.22K0.31%104.22K
JPMorgan Small Cap Blend A95.51K0.29%-
abrdn Healthcare Investors83.25K0.25%8.82K
abrdn Healthcare Opportunities75.75K0.23%7.24K

SGP Ownership FAQ


Who Owns SpyGlass Pharma?

SpyGlass Pharma shareholders are primarily institutional investors at 127.23%, followed by 42.83% insiders and -70.06% retail investors. The average institutional ownership in SpyGlass Pharma's industry, Biotech Stocks , is 35.67%, which SpyGlass Pharma exceeds.

Does Blackrock own SpyGlass Pharma?

BlackRock is not among the top 10 institutional shareholders of SpyGlass Pharma.

Who is the top mutual fund holder of SpyGlass Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SpyGlass Pharma shares, with 0.95% of its total shares outstanding invested in 317.05K SpyGlass Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools